002001:SZSEZhejiang NHU Company Ltd. Analysis
Data as of 2026-06-19 - not real-time
CN¥28.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Undervalued on a fundamental basis – the stock trades at a trailing PE of 12.8x, well below the industry average of 24.1x, and the DCF model suggests a fair value of ≈48 CNY, implying roughly a 37% upside. Revenue is expanding at a healthy 15.7% YoY with robust gross (42.7%) and operating (35%) margins, and ROE sits at a strong 20.4%, all supported by a solid cash position that exceeds debt by nearly 5 billion CNY. The company does not pay a dividend, so income‑focused investors should not count on dividend yield. Technically, the price is hovering just above the 200‑day SMA (28.39) but below the 20‑day (30.11) and 50‑day (32.77) averages, with RSI at 36 indicating slight oversold conditions and a bearish MACD histogram. Volume is trending upward, and the current price of 28 CNY sits near the identified support level of 27.33 CNY, while resistance lies around 32.79 CNY. Market sentiment is in the “Extreme Greed” zone (Fear‑Greed Index 91.5), suggesting bullish bias but also heightened volatility (42% over 30 days) and a recent max drawdown of nearly 30%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near support at 27.33 CNY
- Bearish MACD but RSI indicates slight oversold
- Increasing volume suggests potential bounce
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of ~37% to 48 CNY
- Strong earnings growth and margins
- Technical target near resistance at 32.79 CNY
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term fair value of ~48 CNY indicates >70% upside
- Sustainable cash generation and low net debt
- Sector tailwinds in specialty pharma and nutrition
Key Metrics & Analysis
Financial Health
Revenue Growth15.70%
Profit Margin29.05%
P/E Ratio12.8
ROE20.44%
ROA10.65%
Debt/Equity21.31
P/B Ratio2.5
Op. Cash FlowCN¥8.9B
Free Cash FlowCN¥5.7B
Industry P/E24.1
Technical Analysis
TrendNeutral
RSI36.3
SupportCN¥27.33
ResistanceCN¥32.79
MA 20CN¥30.11
MA 50CN¥32.77
MA 200CN¥28.39
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair ValueCN¥47.88
Target PriceCN¥38.34
Upside/Downside36.93%
GradeUndervalued
TypeBlend
Risk Assessment
Beta-0.10
Volatility42.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.